Additionally, SFRP4 has been included in different gene expression signatures linked to prostate cancer aggressiveness and recurrence10,11, including our previously published signature for non-canonical Wnt pathway and epithelial-to-mesenchymal transition (NCWP-EMT) markers12. This evidence concerns the gene SFRP4 and prostate carcinoma.